Volume 17 (2022)
Volume 16 (2021)
Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
1. Evaluation of Immunohistochemical Findings and Clinical Features associated with Local Aggressiveness in Basal Cell Carcinoma

Simin Shamsi meymandi; Shahriar Dabiri; Alireza ZeynadiniMeymand; Maryam Iranpour; Maryam Khalili; Sorour Alijani; Mahin Aflatoonian

Volume 14, Issue 3 , Summer 2019, , Pages 193-196


  Background & Objective:Basal cell carcinoma (BCC) is classified into BCC1 or low risk (nodular, superficial type) and BCC2 or high risk (micronodular, morpheaform, infiltrative, and basosquamous types) based on clinical behavior. This study attempts to evaluate immunohistochemical (IHC) findings ...  Read More

2. Nodular Cystic Basal Cell Carcinoma of the Trunk: a Diagnostic Dilemma in an Unsuspecting Youth

Ruchita Tyagi; Dilpreet Kaur; Gursheen Kaur; Bhavna Garg; Neena Sood; Sunil Gupta

Volume 12, Issue 4 , Autumn 2017, , Pages 410-412


  Basal cell carcinoma (BCC) commonly affects the elderly and is mostly confined to the head and neck region. Only 10% of all cases occur on the trunk. We presented a case of bullous lesion on the abdomen in a young male, initially diagnosed by clinicians as a vascular nevus. Histopathological examination ...  Read More

3. The Effects of Cyclin D1 and Bcl-2 Expressıon on Aggressive Behavior in Basal Cell and Basosquamous Carcinoma

Oya N. Sivrikoz; Gülşen Kandiloğlu

Volume 10, Issue 3 , Summer 2015, , Pages 185-191


  Background and Objective: Clinical behavior of basal cell carcinoma (BCC) is known to be different according to histological growth pattern and basosquamous cell carcinomas (BSC) are known with their aggressive behavior and metastatic capacity. In this study, we evaluated bcl-2 and cyclin D1 expressions ...  Read More

4. The Usefulness of CD10 in Distinguishing between Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

Shahram Sabeti; Farhad Malekzad; Nastaran Neishaboori; Mihan Pourabdollah Toutkaboni; Farahnaz Bidarizerehpoosh

Volume 9, Issue 4 , Autumn 2014, , Pages 245-250

  Background & Objectives:  CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical ...  Read More

5. Cytodiagnosis of Cutaneous Basal and Squamous Cell Carcinoma

Nourieh Sharifi; Mohammad Javad Yazdanpanah

Volume 2, Issue 3 , Spring 2007, , Pages 97-99

  Background and Objective: Cutaneous cytology is the study of scraping or smears obtained from skin lesions. Although not commonly employed, cutaneous cytology has been a useful tool for clinicians due to simplified procedures and high sensitivity and specificity of presurgical clinical diagnosis of common ...  Read More

6. Evaluation of Diagnostic Values of EMA and Ber-Ep4 in Distinction between Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin

Parvin Rajabi; Mohammad Aboutalebdokht; Mitra Heidarpour; Ali Asilian; Fatemeh Rajabi

Volume 2, Issue 1 , Winter 2007, , Pages 7-10

  Background and Objective: Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are two common tumors of the skin. In some cases, distinction between BCC and SCC can be difficult. This study aimed to clarify this uncertainty through immunohistochemical analysis. In this respect, epithelial membrane ...  Read More